Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The ACR’s Current Healthcare Policy Priorities

From the College  |  Issue: January 2016  |  January 19, 2016

The ACR supports increased investment in federally funded medical research. Currently, the ACR supports $32 billion for NIH funding this fiscal year, NIH funding in the 21st Century Cures legislation, $13 million for the CDC Arthritis Program, and creation of a $20 million dedicated arthritis program at the DOD to better serve veterans living with rheumatic diseases.

Page: 1 2 | Single Page
Share: 

Filed under:From the College Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)Healthcarepublic policy

Related Articles

    Employee Non-Compete Agreements in Physician Practices

    November 16, 2016

    You started a medical practice and, through the years, have developed policies, procedures, strategies, work products, client relationships and confidential information that are specific to your practice and its success. As your practice grows, you know you will need to hire more employees. You also understand, however, that any potential employee may pose a risk…

    Cyber Risks: A New Area of Liability for Medical Practices

    December 16, 2015

    Computerization of healthcare in general, and medical records in particular, has opened additional areas of liability for medical practices that many may not be addressing. A data breach of patient records can have major financial and business impacts on the practice when they occur. Data Intrusions Increasing The number of data intrusions hit a record…

    Medicare D-lemmas

    January 1, 2007

    Rheumatologists and patients report mixed experiences with the new prescription drug benefit

    American College of Rheumatology Leads Charge to Address Excessive Patient Cost Sharing

    August 8, 2012

    The ACR Government Affairs Committee has developed legislative language to limit commercial insurance plans’ cost-sharing requirements for medications in a specialty drug tier to the dollar amount applicable to drugs in the nonpreferred-brand drug tier.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences